Tepotinib

Trade Name: 
Tepmetko
Manufacturer/Distributor: 
EMD Serono
Classification: 
Protein kinase inibitor (antineoplastic agent)
ATC Class: 
L01EX21 - tepotinib
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2021/05/27
Presentation: 
Tablet: 225 mg. DIN 02516322
Comments: 
NOC/C - for treatment of adults with non-small cell lung cancer.
Source: 
Product monograph